High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma.
暂无分享,去创建一个
Yuan-feng Yang | Le Xu | Yuan Chang | Jiejie Xu | Lin Zhou | Zongming Lin | Q. Fu
[1] A. Jemal,et al. Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.
[2] Y. Nordby,et al. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer. , 2015, The American journal of pathology.
[3] B. Ye,et al. Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling , 2015, International journal of immunopathology and pharmacology.
[4] Shailesh Singh,et al. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases , 2015, Oncotarget.
[5] Gang Xiao,et al. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms , 2015, Oncotarget.
[6] Le Xu,et al. Clinical significance of tumor-derived IL-1β and IL-18 in localized renal cell carcinoma: Associations with recurrence and survival. , 2015, Urologic oncology.
[7] Hyun-Sook Kim,et al. CXCL16 and CXCR6 in Ewing sarcoma family tumor. , 2014, Human pathology.
[8] Jing Zhao,et al. Chinese a Nti鄄 Cancer a Ssociation , 2013 .
[9] S. Shariat,et al. Biomarkers in personalised treatment of renal-cell carcinoma. , 2012, The Lancet. Oncology.
[10] Xianghuo He,et al. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. , 2012, Cancer research.
[11] Han Yong Choi,et al. The epidemiology of renal cell carcinoma. , 2011, European urology.
[12] James L. Sherley,et al. CXCR6, a Newly Defined Biomarker of Tissue-Specific Stem Cell Asymmetric Self-Renewal, Identifies More Aggressive Human Melanoma Cancer Stem Cells , 2010, PLoS ONE.
[13] Yan Li,et al. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. , 2010, Biochimica et biophysica acta.
[14] C. Compton,et al. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.
[15] J. Gillespie,et al. The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers , 2009, PloS one.
[16] Jialiang Hu,et al. Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia. , 2009, Cancer letters.
[17] G. Kristiansen,et al. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. , 2009, European journal of cancer.
[18] Jianhua Wang,et al. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. , 2008, Cancer research.
[19] J. Van Damme,et al. The role of CXC chemokines and their receptors in cancer. , 2008, Cancer letters.
[20] Weibing Zhang,et al. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells , 2008, Cancer science.
[21] Jianhua Wang,et al. CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro , 2008, Molecular Cancer Research.
[22] Chih-Hung Hsu,et al. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy , 2006, The Journal of pathology.
[23] J. Cheville,et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.
[24] R. Figlin,et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] F. Harrell,et al. Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .
[26] S. Fuhrman,et al. Prognostic significance of morphologic parameters in renal cell carcinoma , 1982, The American journal of surgical pathology.
[27] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.